Nucleix: Nucleix Bladder EpiCheck Now Available in France via the Association Francaise d'Urologie (AFU) Registry for Surveillance of Recurrence of Bladder Cancer

Nucleix Bladder EpiCheck is a non-invasive CE marked test for detection of primary or recurrent bladder cancer, and U.S. FDA 510(k) cleared for bladder cancer recurrence, in conjunction with stand...